There are 410 resources available
224P - Genetic landscape, PD-L1 expression, and CD8+ infiltration in Chinese pulmonary carcinoids
Presenter: Ning Zhou
Session: Poster Display session
Antibody drug conjugates
Presenter: Daniel Shao Weng Tan
Session: New therapeutic classes: ADCs, bispecifics and novel IO agents
Resources:
Slides
Webcast
Robustness of LDCT program for early detection of lung cancer
Presenter: Harry De Koning
Session: Screening and early detection
Resources:
Slides
Webcast
Immunotherapy mono and combinations in unresectable stage III NSCLC
Presenter: Sophie Guillerm
Session: Present and future of multimodality strategies in stage III NSCLC
Resources:
Slides
Webcast
Bispecific antibodies
Presenter: Fiona Blackhall
Session: New therapeutic classes: ADCs, bispecifics and novel IO agents
Resources:
Slides
Webcast
Improving lung cancer outcomes through prehabilitation: Are we there yet?
Presenter: Morten Quist
Session: Optimising cancer outcomes through supportive care (Cancer nursing session)
Resources:
Slides
Webcast
Steps to implement LDCT programme
Presenter: Silvia Novello
Session: Screening and early detection
Resources:
Slides
Webcast
De-escalation strategies in unresectable stage III NSCLC
Presenter: Matthias Guckenberger
Session: Present and future of multimodality strategies in stage III NSCLC
Resources:
Slides
Webcast
Biomarkers to support screening
Presenter: Luis Montuenga
Session: Screening and early detection
Resources:
Slides
Webcast
Novel checkpoints
Presenter: Jarushka Naidoo
Session: New therapeutic classes: ADCs, bispecifics and novel IO agents
Resources:
Slides
Webcast